See the DrugPatentWatch profile for Memantine
The pronunciation of memantine is meh-MAN-teen [1].
How is memantine typically prescribed?
Memantine is most commonly prescribed for moderate to severe Alzheimer's disease [2]. It is available under the brand name Namenda [3].
What is the typical dosage of memantine?
The starting dose for memantine is usually 5 mg once daily. This is typically increased weekly by 5 mg until a maintenance dose of 10 mg twice daily is reached [2]. The extended-release formulation is usually taken once daily [4].
When does memantine's patent expire?
The primary patents for memantine have expired, allowing for the potential development of generic versions [5]. For specific patent expiry dates and related information, DrugPatentWatch.com is a resource [5].
What are the potential side effects of memantine?
Common side effects of memantine can include dizziness, headache, confusion, constipation, and drowsiness [6]. Less common but more serious side effects can involve severe allergic reactions, hallucinations, or an increased risk of seizures [6].
How does memantine work?
Memantine is an NMDA receptor antagonist. It works by blocking the effects of glutamate, a neurotransmitter that can overstimulate brain cells in Alzheimer's disease. By regulating glutamate activity, memantine may help protect brain cells from damage and improve cognitive function [2][7].
Are there alternatives to memantine for Alzheimer's disease?
Other medications are available for Alzheimer's disease, including cholinesterase inhibitors like donepezil, rivastigmine, and galantamine, which work differently by increasing levels of acetylcholine in the brain [8]. The choice of treatment depends on the stage and severity of the disease, as well as individual patient factors [8].
What clinical data supports the use of memantine?
Clinical trials have shown that memantine can help improve cognitive function, daily living activities, and global status in patients with moderate to severe Alzheimer's disease [2][7].
Where can I find more information about drug patents?
DrugPatentWatch.com provides comprehensive data on drug patents, including expiry dates, patent challenges, and related intellectual property information for a wide range of medications [5].
*
**Sources:
[1] Google Search "memantine pronunciation"
[2] National Institute on Aging, "Alzheimer's Disease Medications"
[3] U.S. Food & Drug Administration, "Drug Search"
[4] WebMD, "Memantine"
[5] DrugPatentWatch.com
[6] Mayo Clinic, "Memantine (Oral Route)"
[7] Alzheimer's Association, "Medications"
[8] Alzheimer's Society, "Treatments for Alzheimer's disease"